Susan Cornell
6 Podcast Episodes
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges - Susan Cornell, PharmD and Anne Peters, MD
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges - Susan Cornell, PharmD and Anne Peters, MD
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges
7 Feb 2020
•
1hr 2mins
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges - Susan Cornell, PharmD and Anne Peters, MD
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges - Susan Cornell, PharmD and Anne Peters, MD
Integrating Insulin Biosimilars into Clinical Practice: New Pathways and New Challenges
7 Feb 2020
•
1hr 2mins
Similar People
Sonia Friedman
Robert Sidbury
Jonathan Kay
Richard Kim
Stanley Cohen
Matt S
Atopic Dermatitis
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Heinz-Josef Lenz
Rakesh Jain
Josep Tabernero
Jean-Yves Douillard
John Cooper
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals - Susan Cornell, PharmD and Randolph V. Fugit, PharmD
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals - Susan Cornell, PharmD and Randolph V. Fugit, PharmD
Recorded during the AHSP Midyear Meeting, this webcast discusses translating outcomes from T2DM cardiovascular trials in... Read more
17 Dec 2019
•
1hr 29mins
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals - Susan Cornell, PharmD and Randolph V. Fugit, PharmD
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals - Susan Cornell, PharmD and Randolph V. Fugit, PharmD
Recorded during the AHSP Midyear Meeting, this webcast discusses translating outcomes from T2DM cardiovascular trials in... Read more
17 Dec 2019
•
1hr 29mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
This webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patien... Read more
1 Nov 2019
•
41mins
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
This webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patien... Read more
1 Nov 2019
•
41mins
